Factors contributing to mortality in paracetamol-induced hepatic failure
Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to th...
Gespeichert in:
Veröffentlicht in: | BMJ 1981-01, Vol.282 (6259), p.199-201 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 201 |
---|---|
container_issue | 6259 |
container_start_page | 199 |
container_title | BMJ |
container_volume | 282 |
creator | Canalese, J Gimson, A E Davis, M Williams, R |
description | Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to the local hospital early enough (within 12 hours) to benefit from protective agents, and only three of these were treated. Treatment was delayed in two patients while the results of plasma paracetamol concentrations were awaited. Signs of grade 3 hepatic encephalopathy were never found until 72 hours after the overdose, and sudden deterioration in consciousness at an earlier stage was due either to the sedative effects of drugs or to hypoglycaemia, which in one patient went unrecognised for 24 hours. A rapid deterioration in prothrombin time, which became prolonged by at least 25 seconds at 48 hours, preceded the onset of grade 3 encephalopathy, and this is the time at which transfer should be arranged to avoid the danger of brain-stem coning. This occurred more rapidly in those transferred at a later stage of their illness. |
doi_str_mv | 10.1136/bmj.282.6259.199 |
format | Article |
fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1503932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>29500304</jstor_id><sourcerecordid>29500304</sourcerecordid><originalsourceid>FETCH-LOGICAL-b540t-7ea2443222b60b3013e1ccb3a2e199c495e483b8922adf7c94ef8192c3993dfc3</originalsourceid><addsrcrecordid>eNqFkMFLHDEchUOp2GX13kthwGOZNckvk0wuhbK4KohCqV5DJpPRbGcm2yRT6n9vll1WPXnK4Xt5efkQ-krwghDg582wXtCaLjit5IJI-QnNCON1WdUAn9EMUy5KzCl8QacxrjHGFEQtOTtGx1wIKZmcoauVNsmHWBg_puCaKbnxsUi-GHxIunfpuXBjsdFBG5v04PvSje1kbFs82Y1OzhSddv0U7Ak66nQf7en-nKP71cXv5VV5c3d5vfx5UzYVw6kUVlPGgFLacNwAJmCJMQ1oavMPDJOVZTU0taRUt50wktmuJpIakBLazsAc_dj1bqZmsK2xebbu1Sa4QYdn5bVT78nontSj_6dIhUECzQVn-4Lg_042JrX2UxjzZkWE4MCxyMk5wruUCT7GYLvDCwSrrX2V7atsX23tq7w9X_n2dtnhwt71K1_HbPyAqawwBswyL3fcxWT_H7gOf3IFiErdPixVfcsY-7UCtcr577v8dsmH614A6XKnhg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776360750</pqid></control><display><type>article</type><title>Factors contributing to mortality in paracetamol-induced hepatic failure</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>PubMed Central</source><creator>Canalese, J ; Gimson, A E ; Davis, M ; Williams, R</creator><creatorcontrib>Canalese, J ; Gimson, A E ; Davis, M ; Williams, R</creatorcontrib><description>Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to the local hospital early enough (within 12 hours) to benefit from protective agents, and only three of these were treated. Treatment was delayed in two patients while the results of plasma paracetamol concentrations were awaited. Signs of grade 3 hepatic encephalopathy were never found until 72 hours after the overdose, and sudden deterioration in consciousness at an earlier stage was due either to the sedative effects of drugs or to hypoglycaemia, which in one patient went unrecognised for 24 hours. A rapid deterioration in prothrombin time, which became prolonged by at least 25 seconds at 48 hours, preceded the onset of grade 3 encephalopathy, and this is the time at which transfer should be arranged to avoid the danger of brain-stem coning. This occurred more rapidly in those transferred at a later stage of their illness.</description><identifier>ISSN: 0267-0623</identifier><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>DOI: 10.1136/bmj.282.6259.199</identifier><identifier>PMID: 6779949</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Acetaminophen - poisoning ; Adult ; Blood plasma ; Chemical and Drug Induced Liver Injury ; Critical Care ; Encephalopathies ; Female ; Grade 3 ; Hepatic encephalopathy ; Hepatic Encephalopathy - chemically induced ; Humans ; Liver ; Liver Diseases - mortality ; Liver Diseases - therapy ; Liver failure ; Male ; Mortality ; Necrosis ; Occasional Review ; Overdose ; Protective agents ; Retrospective Studies ; Time Factors</subject><ispartof>BMJ, 1981-01, Vol.282 (6259), p.199-201</ispartof><rights>Copyright 1981 British Medical Journal</rights><rights>Copyright BMJ Publishing Group LTD Jan 17, 1981</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b540t-7ea2443222b60b3013e1ccb3a2e199c495e483b8922adf7c94ef8192c3993dfc3</citedby><cites>FETCH-LOGICAL-b540t-7ea2443222b60b3013e1ccb3a2e199c495e483b8922adf7c94ef8192c3993dfc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/29500304$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/29500304$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,803,885,27922,27923,53789,53791,58015,58248</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6779949$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Canalese, J</creatorcontrib><creatorcontrib>Gimson, A E</creatorcontrib><creatorcontrib>Davis, M</creatorcontrib><creatorcontrib>Williams, R</creatorcontrib><title>Factors contributing to mortality in paracetamol-induced hepatic failure</title><title>BMJ</title><addtitle>Br Med J (Clin Res Ed)</addtitle><description>Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to the local hospital early enough (within 12 hours) to benefit from protective agents, and only three of these were treated. Treatment was delayed in two patients while the results of plasma paracetamol concentrations were awaited. Signs of grade 3 hepatic encephalopathy were never found until 72 hours after the overdose, and sudden deterioration in consciousness at an earlier stage was due either to the sedative effects of drugs or to hypoglycaemia, which in one patient went unrecognised for 24 hours. A rapid deterioration in prothrombin time, which became prolonged by at least 25 seconds at 48 hours, preceded the onset of grade 3 encephalopathy, and this is the time at which transfer should be arranged to avoid the danger of brain-stem coning. This occurred more rapidly in those transferred at a later stage of their illness.</description><subject>Acetaminophen - poisoning</subject><subject>Adult</subject><subject>Blood plasma</subject><subject>Chemical and Drug Induced Liver Injury</subject><subject>Critical Care</subject><subject>Encephalopathies</subject><subject>Female</subject><subject>Grade 3</subject><subject>Hepatic encephalopathy</subject><subject>Hepatic Encephalopathy - chemically induced</subject><subject>Humans</subject><subject>Liver</subject><subject>Liver Diseases - mortality</subject><subject>Liver Diseases - therapy</subject><subject>Liver failure</subject><subject>Male</subject><subject>Mortality</subject><subject>Necrosis</subject><subject>Occasional Review</subject><subject>Overdose</subject><subject>Protective agents</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><issn>0267-0623</issn><issn>0959-8138</issn><issn>1468-5833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkMFLHDEchUOp2GX13kthwGOZNckvk0wuhbK4KohCqV5DJpPRbGcm2yRT6n9vll1WPXnK4Xt5efkQ-krwghDg582wXtCaLjit5IJI-QnNCON1WdUAn9EMUy5KzCl8QacxrjHGFEQtOTtGx1wIKZmcoauVNsmHWBg_puCaKbnxsUi-GHxIunfpuXBjsdFBG5v04PvSje1kbFs82Y1OzhSddv0U7Ak66nQf7en-nKP71cXv5VV5c3d5vfx5UzYVw6kUVlPGgFLacNwAJmCJMQ1oavMPDJOVZTU0taRUt50wktmuJpIakBLazsAc_dj1bqZmsK2xebbu1Sa4QYdn5bVT78nontSj_6dIhUECzQVn-4Lg_042JrX2UxjzZkWE4MCxyMk5wruUCT7GYLvDCwSrrX2V7atsX23tq7w9X_n2dtnhwt71K1_HbPyAqawwBswyL3fcxWT_H7gOf3IFiErdPixVfcsY-7UCtcr577v8dsmH614A6XKnhg</recordid><startdate>19810117</startdate><enddate>19810117</enddate><creator>Canalese, J</creator><creator>Gimson, A E</creator><creator>Davis, M</creator><creator>Williams, R</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>19810117</creationdate><title>Factors contributing to mortality in paracetamol-induced hepatic failure</title><author>Canalese, J ; Gimson, A E ; Davis, M ; Williams, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b540t-7ea2443222b60b3013e1ccb3a2e199c495e483b8922adf7c94ef8192c3993dfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Acetaminophen - poisoning</topic><topic>Adult</topic><topic>Blood plasma</topic><topic>Chemical and Drug Induced Liver Injury</topic><topic>Critical Care</topic><topic>Encephalopathies</topic><topic>Female</topic><topic>Grade 3</topic><topic>Hepatic encephalopathy</topic><topic>Hepatic Encephalopathy - chemically induced</topic><topic>Humans</topic><topic>Liver</topic><topic>Liver Diseases - mortality</topic><topic>Liver Diseases - therapy</topic><topic>Liver failure</topic><topic>Male</topic><topic>Mortality</topic><topic>Necrosis</topic><topic>Occasional Review</topic><topic>Overdose</topic><topic>Protective agents</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Canalese, J</creatorcontrib><creatorcontrib>Gimson, A E</creatorcontrib><creatorcontrib>Davis, M</creatorcontrib><creatorcontrib>Williams, R</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Canalese, J</au><au>Gimson, A E</au><au>Davis, M</au><au>Williams, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors contributing to mortality in paracetamol-induced hepatic failure</atitle><jtitle>BMJ</jtitle><addtitle>Br Med J (Clin Res Ed)</addtitle><date>1981-01-17</date><risdate>1981</risdate><volume>282</volume><issue>6259</issue><spage>199</spage><epage>201</epage><pages>199-201</pages><issn>0267-0623</issn><issn>0959-8138</issn><eissn>1468-5833</eissn><abstract>Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to the local hospital early enough (within 12 hours) to benefit from protective agents, and only three of these were treated. Treatment was delayed in two patients while the results of plasma paracetamol concentrations were awaited. Signs of grade 3 hepatic encephalopathy were never found until 72 hours after the overdose, and sudden deterioration in consciousness at an earlier stage was due either to the sedative effects of drugs or to hypoglycaemia, which in one patient went unrecognised for 24 hours. A rapid deterioration in prothrombin time, which became prolonged by at least 25 seconds at 48 hours, preceded the onset of grade 3 encephalopathy, and this is the time at which transfer should be arranged to avoid the danger of brain-stem coning. This occurred more rapidly in those transferred at a later stage of their illness.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>6779949</pmid><doi>10.1136/bmj.282.6259.199</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0267-0623 |
ispartof | BMJ, 1981-01, Vol.282 (6259), p.199-201 |
issn | 0267-0623 0959-8138 1468-5833 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1503932 |
source | MEDLINE; JSTOR Archive Collection A-Z Listing; PubMed Central |
subjects | Acetaminophen - poisoning Adult Blood plasma Chemical and Drug Induced Liver Injury Critical Care Encephalopathies Female Grade 3 Hepatic encephalopathy Hepatic Encephalopathy - chemically induced Humans Liver Liver Diseases - mortality Liver Diseases - therapy Liver failure Male Mortality Necrosis Occasional Review Overdose Protective agents Retrospective Studies Time Factors |
title | Factors contributing to mortality in paracetamol-induced hepatic failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A16%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20contributing%20to%20mortality%20in%20paracetamol-induced%20hepatic%20failure&rft.jtitle=BMJ&rft.au=Canalese,%20J&rft.date=1981-01-17&rft.volume=282&rft.issue=6259&rft.spage=199&rft.epage=201&rft.pages=199-201&rft.issn=0267-0623&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.282.6259.199&rft_dat=%3Cjstor_pubme%3E29500304%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776360750&rft_id=info:pmid/6779949&rft_jstor_id=29500304&rfr_iscdi=true |